Zih-Liang Yang from The University of Sheffield visited the ViraVector facilities at GeneT, The University of Coimbra, as part of the Accelerating Research & Development for Advanced Therapies (ARDAT) project. ARDAT aims to accelerate the research and development of advanced therapy medicinal products (ATMPs), with a strong focus on rare genetic diseases.
The visit involved a technology transfer and training program covering several standardized operating procedures (SOPs) related to key analytical techniques — including ELISA, qPCR, ddPCR, and Next-Generation Sequencing (NGS) — used for the quantification of AAV viral titers.
This collaboration represented an important step towards:
- Harmonizing analytical workflows across institutions;
- Strengthening our expertise in viral vector characterization;
- Ensuring reproducibility and consistency in AAV quantification methods;
- Building stronger connections within the ARDAT consortium
For more information follow the link.
